IMU (ASX) Why IMU is a multi multi bagger

Originally posted by davybabyk: ↑

Hi Bluegum

Sorry to hear about your friend. I'm not a Dr, let alone an Oncologist, but I think the answer is potentially "yes." CF33 in preclinical trials was effective against pretty much every solid cancer type. So when they set up the MAST trial they decided to make it open to patients with "Any histologically or cytologically confirmed advanced or metastatic solid tumor."

The idea being - lets see if it is effective in human subjects against a wide range of solid cancer types - and then choose one or more specific types where we have the best chance of FDA support for a "Fast Track" to registration. They have achieved "Fast Track" for Biliary Cancer, but I'm sure that's just the start, because - so far - they do indeed seem be getting good results across a wide range of cancer types.

I haven't seen Endometrial Cancer mentioned yet - but I think it would be a cancer they are happy to include in the study.

The complete set of "Eligibility Criteria" is quite complex though. Here it is:
Eligibility Criteria
Description
Inclusion Criteria:
Written informed consent from subject or legally authorized representative.
Age ≥ 18 years old on the date of consent.
Life expectancy of at least 3 months.
Any histologically or cytologically confirmed advanced or metastatic solid tumor with documented radiological progression per RECIST v1.1 following at least one prior line of treatment. Eligible subjects must have received at least two prior lines of approved therapies, including targeted therapies, for which they are eligible and failed or relapsed on or after that treatment.
Eastern Cooperative Oncology Group (ECOG) performance status 0 - 1.
At least one measurable lesion as defined by RECIST v1.1 criteria.
Adequate renal function.
Adequate hepatic function.
Adequate hematologic function.
Willing and able to comply with scheduled visits, study treatment plan, laboratory tests, and other study procedures.
Exclusion Criteria:
Prior treatment with an oncolytic virus or a bispecific CD19-directed CD3 T-cell engager.
Continuous systemic treatment with either corticosteroids (>10 mg daily prednisone equivalents) or other immunosuppressive medications within 4 weeks prior to first dose of study treatment.
Any radiation within 2 weeks of start of study treatment.
Active autoimmune disease.
Current or history of severe skin disease with open wounds.
History of (non-infectious) pneumonitis / interstitial lung disease that required steroids or has current pneumonitis / interstitial lung disease.
History of pancreatitis.
> Grade 2 neuropathy.
Prior allogeneic tissue/organ transplant or other medical conditions requiring ongoing treatment with immunosuppressive drugs or any condition resulting in a systemic immunosuppressed state.
History or presence of brain or other central nervous system (CNS) metastases.
History of documented congestive heart failure (New York Heart Association [NYHA] class II - IV), unstable angina, poorly controlled hypertension, clinically significant valvular heart disease or high-risk uncontrolled arrhythmias.
Bleeding diathesis due to underlying medical condition or ongoing anticoagulation medication.
History or presence of clinically relevant CNS pathology, or any other CNS disability judged by the Investigator to be clinically significant and precluding informed consent or participation in the study.
Active infection requiring systemic treatment.
Source: https://clinicaltrials.gov/study/NCT06063317?term=%22Imugene%22&rank=1#participation-criteria

I hope your friend makes a full recovery.

Best regards

Dave

Expand

I think someone should develop an app that takes in the data outlines a simple process?

No.	Vol.	Price($)
30	670524	7.1¢

No.

Vol.

Price($)

670524

7.1¢

Price($)	Vol.	No.
7.2¢	371513	16

Price($)

Vol.

No.

7.2¢

371513

No.	Vol.	Price($)
30	670524	0.071
23	2489948	0.070
7	2372466	0.069
29	3310370	0.068
16	2186858	0.067

No.

Vol.

Price($)

670524

0.071

2489948

0.070

2372466

0.069

3310370

0.068

2186858

0.067

Price($)	Vol.	No.
0.072	372956	16
0.073	719545	12
0.074	1442617	10
0.075	971483	14
0.076	893927	10

Price($)

Vol.

No.

0.072

372956

0.073

719545

0.074

1442617

0.075

971483

0.076

893927

(20min delay)
Last 7.2¢		Change -0.004(4.67%)		Mkt cap ! $523.3M

Open	High	Low	Value	Volume
7.5¢	7.5¢	6.8¢	$2.581M	36.42M


Last 7.1¢		Change -0.004 ( 4.83 %)
Open	High	Low	Volume
7.4¢	7.4¢	6.8¢	18096764
Last updated 15.00pm 13/05/2024 ?

Why IMU is a multi multi bagger, page-20598

Featured News

Magnum to raise US$210M to advance Saudi green pig iron plant

D3E joins ASX as it hunts natural gas and helium in South Africa

Meet Sun Silver – ASX's newest silver-gold player based in Nevada, USA

Errawarra's pegmatite discovery in WA Pilbara strikes gold on ASX

Fletcher Building navigates uncertain market dynamics in FY24

Buyers (Bids)

Sellers (Offers)

Featured News

Why IMU is a multi multi bagger, page-20598

Featured News

Top Stories

Magnum to raise US$210M to advance Saudi green pig iron plant

D3E joins ASX as it hunts natural gas and helium in South Africa

Meet Sun Silver – ASX's newest silver-gold player based in Nevada, USA

Errawarra's pegmatite discovery in WA Pilbara strikes gold on ASX

Fletcher Building navigates uncertain market dynamics in FY24

Buyers (Bids)

Sellers (Offers)

Featured News